Canaccord Genuity Group Cuts Edwards Lifesciences (NYSE:EW) Price Target to $66.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price target decreased by Canaccord Genuity Group from $77.00 to $66.00 in a research report report published on Monday, Benzinga reports. Canaccord Genuity Group currently has a hold rating on the medical research company’s stock. Several other brokerages also recently weighed in on EW. Daiwa Capital Markets […]
11 Oct 05:44 · The Cerbat Gem